EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.0434
March 31, 2026 -0.0512
December 31, 2025 -0.0376
September 30, 2025 -0.0632
June 30, 2025 -0.1057
March 31, 2025 -0.1372
December 31, 2024 -0.1689
September 30, 2024 -0.2459
June 30, 2024 -0.1758
March 31, 2024 -0.2713
December 31, 2023 -0.2645
September 30, 2023 -0.2223
June 30, 2023 -0.1596
Date Value
March 31, 2023 -0.2121
December 31, 2022 -0.1787
September 30, 2022 -0.2877
June 30, 2022 -0.2546
March 31, 2022 -0.1711
December 31, 2021 -0.3394
September 30, 2021 -0.2255
June 30, 2021 -0.129
March 31, 2021 -0.0413
September 30, 2020 -0.1296
June 30, 2020 -0.1243
March 31, 2020 -0.1622

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Bristol Myers Squibb Co. 1.053
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 0.0858

EPS Diluted (Quarterly) Related Metrics